The increased production of adipokines such as leptin or adiponectin leads to metabolic syndrome, insulin resistance, and the development of non-alcoholic fatty liver disease [28,106,107,108]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.